Your browser doesn't support javascript.
loading
Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy.
Cao, Weihua; Lu, Huihui; Zhang, Luxue; Wang, Shiyu; Deng, Wen; Jiang, Tingting; Lin, Yanjie; Yang, Liu; Bi, Xiaoyue; Lu, Yao; Zhang, Lu; Shen, Ge; Liu, Ruyu; Chang, Min; Wu, Shuling; Gao, Yuanjiao; Hao, Hongxiao; Xu, Mengjiao; Chen, Xiaoxue; Hu, Leiping; Xie, Yao; Li, Minghui.
Afiliación
  • Cao W; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Lu H; Department of Infectious Diseases, Miyun Teaching Hospital, Capital Medical University, Beijing, China.
  • Zhang L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Wang S; Department of Obstetrics and Gynecology, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Deng W; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Jiang T; Infectious Disease Department, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Lin Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Yang L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Bi X; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Lu Y; Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing, China.
  • Zhang L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Shen G; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Liu R; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Chang M; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Wu S; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Gao Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Hao H; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Xu M; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Chen X; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Hu L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Xie Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Li M; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Front Immunol ; 13: 1067362, 2022.
Article en En | MEDLINE | ID: mdl-36479104
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis B Crónica / Antígenos de Superficie de la Hepatitis B Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis B Crónica / Antígenos de Superficie de la Hepatitis B Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza